Improved chest CT diagnostics and contrast medium administration.
Should ultra low dose CT replace the chest x-ray as the first choice of referral in lung diagnostics?
Long-term clinical respiratory outcomes in patients hospitalized with COVID-19 infection. PROLUN and NOR-SOLIDARITY sub studies
Optimisation of CT thorax using hyperdrive and AI based reconstruction, phantom studies and clinical study.
Differentiation betweenintrapulmonary lymph nodes and early stage lung metastases from colorectal cancer based on chest CT
Radiologic characterization of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency. Cross-sectional studies on the unselected patient cohorts.
In collaboration with the Department of Rheumatology and Department of Pulmonology several ongoing inter-disciplinary, cross-sectional studies on interstitial lung disease in idiopathic disorders and patient cohorts with connective tissue diseases and primary vasculitidis
Kastrati K, Sprecher M, Weber F, Langballe E, Molnar D, Göthans LT, Anderle K, Fretheim H, Jenssen Bjørkekjær H, Diep PP, Mæhlen M, Mrak D, Rempp N, Müller-Durovic B, Brunborg C, Vieira A, Correia AC, Bouillot C, Bruni C, Clarenbach C, Frauenfelder T, Aaløkken TM, Moe N, Prosch H, Midtvedt Ø, Andersson H, Studenic P, Molberg Ø, Aletaha D, Distler Oet al.(2026) Treatment patterns, disease progression and survival in Sjögren disease-associated interstitial lung disease: a multicentre European cohort study J Autoimmun, 163, 103611(in press) DOI 10.1016/j.jaut.2026.103611, PubMed 42561460
Stavem K, Einvik G, Lerum TV, Meltzer C, Rodriguez JR, Ashraf H, Lakxsan SR, Gleditsch J, Skjønsberg OH, Aaløkken TM(2026) Long-term chest CT abnormalities up to 4.5 years after COVID-19 hospitalization and their association with dyspnea and fatigue: a prospective cohort study Respir Res(in press) DOI 10.1186/s12931-026-03771-7, PubMed 42332713
Thunold S, Hernes E, Gyland Mikalsen LT, Farooqi S, Öjlert ÅK, Francis RJ, Nowak AK, Szejniuk WM, Nielsen SS, Cedres S, Perdigo MS, Sørensen JB, Meltzer C, Helland Å, Malinen E, Haakensen VD(2026) Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy EJNMMI Res, 16(1) DOI 10.1186/s13550-026-01469-x, PubMed 42322509
Get in touch
Trond Mogens Aaløkken, Group leader, Consultant; MD, PhD Department of Radiology, Rikshospitalet, taalokke@ous-hf.no Mob. 95906881